Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Dr Kristina Zec has been awarded a Versus Arthritis Foundation Fellowship to investigate the role of products of lipid oxidation produced by synovial macrophages in triggering articular inflammation.

Kristina Zec

Working in the Udalova Group, the 36-month fellowship will enable Kristina to also assess some novel approaches to limiting disease by a combination of therapeutics and diet.  

Kristina said: “I am extremely happy and honoured to have received a Versus Arthritis Foundation Fellowship. The project I have developed with Irina’s support has translational potential and will significantly expand our understanding of RA pathology. It will dissect the lipid cues involved in communication between gatekeeping macrophages and neutrophils in arthritis. 

“I believe that lipid language can be modified through changing lipid composition of cellular membranes and by altering lipid processing.  I plan to explore these two ways of changing the lipid language of inflammation to discover and deliver novel treatments.  I am excited to embark on a quest of answering these questions in a highly supportive and inspiring environment of my group and the Kennedy Institute." 

Similar stories

New children’s orthopaedic hospital opens in Zimbabwe

Main

A new children’s orthopaedic hospital in Bulawayo that will treat children across Zimbabwe who are living with musculoskeletal impairments has opened today.

Professor Katja Simon elected to the Academy of Medical Sciences

Awards Kennedy Main

Professor of Immunology Katja Simon has been elected as a Fellow of the Academy of Medical Sciences.

3,400 different medicines used globally to treat COVID-19

Main Statistics and epidemiology

Insufficient data, and misleading recommendations led to significant early heterogeneity in global COVID-19 patient management, according to recent BMJ study

Clinical trial finds Azithromycin has no benefit against COVID-19

Main OCTRU

A clinical trial by University of Oxford researchers has confirmed that the antibiotic azithromycin has no clinical benefit in people with moderate COVID-19.

Study reveals the three most important aspects of care for hip fractures

Hip Main OCTRU Research Trauma

Older patients with hip fractures recover better if they receive treatment under the supervision of both a surgeon and a specialist in elderly care; are checked to avoid future falls; and are assessed for memory problems.

Major ERC funding awarded to Professor Michael Dustin

Awards Kennedy Main

Professor Michael Dustin and an international team of collaborators have been awarded a €10M grant from the European Research Council (ERC) to develop a new biotechnology around supramolecular attack particles (SMAPs) engineered to kill cancer cells.